Drug Type Universal CAR-T |
Synonyms |
Target |
Mechanism CD7 inhibitors(T-cell antigen CD7 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Phase 1 | - | - | |
CD7 Positive Acute Myeloid Leukemia | Preclinical | CN | 11 Apr 2024 |